Provided by Tiger Trade Technology Pte. Ltd.

InMed Pharmaceuticals Inc

1.35
-0.0300-2.17%
Post-market: 1.350.00000.00%19:30 EDT
Volume:90.05K
Turnover:123.67K
Market Cap:7.21M
PE:-0.53
High:1.42
Open:1.36
Low:1.35
Close:1.38
52wk High:2.50
52wk Low:0.5750
Shares:5.34M
Float Shares:1.93M
Volume Ratio:0.93
T/O Rate:4.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5324
EPS(LYR):-8.3630
ROE:-112.65%
ROA:-54.61%
PB:1.05
PE(LYR):-0.16

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 23, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 23, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 22, 2026

Major Issues Report

Form 8-K - Current report
Jul 20, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 27, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2026

Major Issues Report

Form 8-K - Current report
Apr 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

Correspondence

Form CORRESP - Correspondence
Mar 23, 2026

Major Issues Report

Form 8-K - Current report